Patent · US Active

Hyperactive PiggyBac transposases

US10287559B2 · kind B2 · utility

3Cited by

15References

17Claims

0Family size

Assignee

Poseida Therapeutics, Inc. · US

Inventors

Eric M. Ostertag · San Diego, US
Blair Madison · Philadelphia, US

Key dates

Filing date	Jul 28, 2016
Grant date	May 14, 2019
Priority date	—
Expiry date	Jul 28, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2800/90
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides PiggyBac transposase proteins, nucleic acids encoding the same, compositions comprising the same, kits comprising the same, non-human transgenic animals comprising the same, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.